DTP Vaccines Global Market Report 2024

DTP Vaccines Global Market Report 2024 – By Product type (DTaP, TD, Tdap), By Disease (Diphtheria, Pertussis, Tetanus), By End-User (Hospitals, Clinics, Vaccination Centers) – Market Size, Trends, And Global Forecast 2024-2033

Name: DTP Vaccines Global Market Report 2024
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

DTP Vaccines Global Market Report 2024

Starting Price : $5000.00 $4000.00 | Pages : 250 | Published : March 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

DTP Vaccines Market Definition

Diphtheria, Tetanus, Pertussis (DTP) vaccines refer to a combination vaccine given intramuscularly to protect children under the age of 7 from diphtheria, tetanus, and whooping cough. It aids kids in acquiring resistance to the three bacterial illnesses, diphtheria, tetanus, and pertussis, which are all fatal.

The main types of products in DTP vaccines are DTaP, TD, and Tdap. Diphtheria, tetanus, and whooping cough (DTaP) vaccines help children under the age of seven build protection against three lethal bacteria-borne diseases: diphtheria, tetanus, and whooping cough (pertussis). The different types of diseases include diphtheria, pertussis, and tetanus and involve various sectors such as hospitals, clinics, and vaccination centers.

DTP Vaccines Market Segmentation

The dtp vaccines market covered in this report is segmented –

1) By Product type: DTaP, TD, Tdap

2) By Disease: Diphtheria, Pertussis, Tetanus

3) By End-User: Hospitals, Clinics, Vaccination Centers

Global DTP Vaccines Market Size 2023 to 2028: Graph

DTP Vaccines Market Size 2024 And Growth Rate

The dtp vaccines market size has grown strongly in recent years. It will grow from $6.13 billion in 2023 to $6.56 billion in 2024 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to increase in healthcare access, continuous protection towards infectious diseases and rising awareness of immunization.

DTP Vaccines Market Growth Forecast

The dtp vaccines market size is expected to see strong growth in the next few years. It will grow to $8.63 billion in 2028 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to strong late-stage pipeline and new drug approvals, increased healthcare expenditure and immunization policies to eradicate endemic diseases. Major trends in the forecast period include focusing on development of combination vaccines, investing extensively in r&d activities, using artificial intelligence (ai) in vaccine development and focusing on strategic acquisitions.

Book your 30 minutes free consultation with our research experts

DTP Vaccines Market Driver: Government Initiatives Propel Development And Adoption Of Dtp Vaccines

Governments all over the world are encouraging the development of DTP vaccines in order to prevent the spread of the disease. Countries such as India have the Universal Immunization Programme that aims to provide recommended vaccines against tuberculosis, polio, and other diseases including diphtheria, tetanus, and whooping cough for all Indian children. The country regularly conducts vaccination drives, which are expected to positively impact the growth of the market. These initiatives are expected to drive the growth of the market in the forecast period.

DTP Vaccines Market Driver: Rising Healthcare Expenditure Fuels Growth In The Dtp Vaccine Market

The increasing healthcare expenditure is expected to propel the growth of the DTP vaccine market going forward. Healthcare expenditure refers to the total amount of money spent on healthcare goods and services, including medical equipment, hospital services, physician services, prescription drugs, and public health activities. Healthcare expenditure is instrumental in creating an environment that fosters the development, production, distribution, and effective utilization of DTP vaccines. For instance, in May 2023, the Office for National Statistics, a UK-based statistics authority, reported that healthcare spending in the UK increased by 9.4% in nominal terms and 9.7% in real terms. UK total healthcare expenditure in 2021 was $367.25 billion (£280.7 billion), and pharmaceutical expenditure was $51.84 billion (£39.6 billion) in 2021. Furthermore, spending on preventive care was $45.93 billion (£35.1 billion) in 2021, more than doubling from the previous year. Therefore, the increasing healthcare expenditure is driving the growth of the DTP vaccine market.

Global DTP Vaccines Market Major Players

Major companies operating in the dtp vaccines market report are GlaxoSmithKline, Sanofi, Merck & Co Inc, Meiji Holdings Co., Ltd, Shenzhen Kangtai Biological Products, Serum Institute of India Pvt Ltd, Sun Pharmaceutical Industries Ltd, AJ Vaccines, PT Bio Farma, Bio Med, Sinergium Biotech SA, Teuto Brasileiro, Amgen, Roche, BioFabri, Sinopharm, Chongqing Zhifei, Hualan Biological Engineering Inc, Ezequiel Dias Foundation (FUNED), BioKangtai, Uniao Quimica, Valneva SE, The Abu Dhabi Health Services Company (SEHA), ImevaX GmbH, Cristalia, Bharat Biotech, Bio-Manguinhos–Institute of Technology on Immunobiologicals, Connaught Laboratories Inc, Biolab Farmaceutica, Massbiologics, Beijing Tiantan Biological Products Co Ltd, Butantan Institute, C.R.I. Kasauli, Bayer, Pfizer, Abbott Laboratories, Serum Institute of India Pvt Ltd, Novartis, Wyeth-Ayerst, Dano Vaccines, Merck Serono Middle East, Hypermarcas, AstraZeneca, Grifols, Sinovac Biotech Ltd, AbbVie Inc, Apotex, GreenSignal Bio Pharma Private Limited (GSBPL), Teva Pharmaceutical Industries Ltd F. Hoffmann-La Roche AG, Boehringer Ingelheim, CanSino Biologics, Gilead Sciences, Panacea Biotec Ltd, Fiocruz, Johnson & Johnson, Walvax biotechnology, BioNTech, EMS Pharma, Mylan, National Administration of Laboratories and Institutes of Health (ANLIS), Zentiva, Afrigen Biologics & Vaccines

Global DTP Vaccines Market Restraint: Dtp Vaccine Market Faces Challenges Due To Inadequate Access In Developing Nations

Inadequate vaccine access in developing countries is expected to limit the growth of the global DTP vaccine market. According to the World Health Organization’s global estimates, around 19.4 million infants do not have access to DTP vaccines, and around 60% of these children live in underdeveloped and developing countries. Countries such as the Central African Republic, Chad, Equatorial Guinea, Guinea, Samoa, Somalia, South Sudan, the Syrian Arab Republic, and Ukraine have less than 50% coverage of DTP vaccination. Lack of access to vaccines in underdeveloped countries is expected to hamper market growth.

Global DTP Vaccines Market Trend: Innovative In Vaccine Paving The Way For Enhanced Protection Of Adolescents, Adults, And Unborn Children

Major companies operating in the diphtheria, tetanus, and pertussis (DTP) vaccine market are focusing on developing innovative vaccines such as BOOSTRIX to gain a competitive edge in the market. BOOSTRIX is a vaccine used to help protect adolescents (ages 10–18) and adults against certain diseases caused by bacteria called Bordetella pertussis, diphtheria, and tetanus. It's a combination vaccine that helps prevent whooping cough (pertussis), diphtheria, and tetanus. For instance, in October 2022, GSK plc, a UK-based biotechnology and pharmaceutical company, launched BOOSTRIX, which received approval from the US Food and Drug Administration (FDA). This is the first vaccine that has been specifically licensed for use by pregnant women to protect unborn children from illness. It enhances the mother's antibodies, which are passed on to the growing baby when given during pregnancy.

Global DTP Vaccines Market Trend: Advancements In Dtp Combination Vaccines Streamlining Immunization For Enhanced Protection

Companies in the DTP vaccines market are increasingly investing in manufacturing DTP combination vaccines, which reduce the need for multiple vaccination shots for immunization against infectious diseases. DTP combination vaccines such as tetravalent (DTP-HepB), pentavalent (DTP-HepB-Hib), and hexavalent (DTP-Hib-HepB-IPV) are available to provide the same protection as individual vaccine shots given separately.

DTP Vaccines Market Merger And Acquisition: Gsk Plc Strengthens Portfolio With Acquisition Of Affinivax, Inc. And Advances Next-Generation Pneumococcal Vaccine Development

In August 2022, GSK plc, a UK-based biotechnology and pharmaceutical company, acquired Affinivax, Inc. for $2.1 billion. With this acquisition, GSK is advancing its objective of assembling a potent portfolio of specialized drugs and vaccines. It comprises AFX3772, a candidate for the next-generation 24-valent pneumococcal vaccine that is based on the incredibly ground-breaking Multiple Antigen Presenting System (MAPSTM) platform technology and is currently in phase II development. Affinivax, Inc. is a US-based biotechnology company producing preventative and therapeutic vaccines using a next-generation approach to vaccine technology.

Regional Analysis For The Global DTP Vaccines Market

North America was the largest region in the DTP vaccines market in 2023. The regions covered in the dtp vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the dtp vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The DTP vaccine market consists of sales of Daptacel, Infanrix, Kinrix, Paediarix, Pentacel, Quadracel, and Vaxelis vaccines. Values in this market are "factory gate values," that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The DTP vaccines market research report is one of a series of new reports from The Business Research Company that provides DTP vaccines market statistics, including global market size, regional shares, competitors with a DTP vaccines market share, detailed DTP vaccines market segments, market trends and opportunities, and any further data you may need to thrive in the DTP vaccines industry. This DTP vaccines market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

DTP Vaccines Report Forecast And Analysis

Report Attribute	Details
Market Size Value In 2024	$6.56 billion
Revenue Forecast In 2033	$8.63 billion
Growth Rate	CAGR of 7.1% from 2024 to 2033
Base Year For Estimation	2023
Actual Estimates/Historical Data	2018-2023
Forecast Period	2024 - 2028 - 2033
Market Representation	Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered	1) By Product type: DTaP, TD, Tdap 2) By Disease: Diphtheria, Pertussis, Tetanus 3) By End-User: Hospitals, Clinics, Vaccination Centers
Regional Scope	Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report for an additional fee: Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	GlaxoSmithKline; Sanofi; Merck & Co Inc; Meiji Holdings Co., Ltd; Shenzhen Kangtai Biological Products; Serum Institute of India Pvt Ltd; Sun Pharmaceutical Industries Ltd; AJ Vaccines; PT Bio Farma; Bio Med; Sinergium Biotech SA; Teuto Brasileiro; Amgen; Roche; BioFabri; Sinopharm; Chongqing Zhifei; Hualan Biological Engineering Inc; Ezequiel Dias Foundation (FUNED); BioKangtai; Uniao Quimica; Valneva SE; The Abu Dhabi Health Services Company (SEHA); ImevaX GmbH; Cristalia; Bharat Biotech; Bio-Manguinhos–Institute of Technology on Immunobiologicals; Connaught Laboratories Inc; Biolab Farmaceutica; Massbiologics; Beijing Tiantan Biological Products Co Ltd; Butantan Institute; C.R.I. Kasauli; Bayer; Pfizer; Abbott Laboratories; Serum Institute of India Pvt Ltd; Novartis; Wyeth-Ayerst; Dano Vaccines; Merck Serono Middle East; Hypermarcas; AstraZeneca; Grifols; Sinovac Biotech Ltd; AbbVie Inc; Apotex; GreenSignal Bio Pharma Private Limited (GSBPL); Teva Pharmaceutical Industries Ltd F. Hoffmann-La Roche AG; Boehringer Ingelheim; CanSino Biologics; Gilead Sciences; Panacea Biotec Ltd; Fiocruz; Johnson & Johnson; Walvax biotechnology; BioNTech; EMS Pharma; Mylan; National Administration of Laboratories and Institutes of Health (ANLIS); Zentiva; Afrigen Biologics & Vaccines
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. DTP Vaccines Market Characteristics

3. DTP Vaccines Market Trends And Strategies

4. DTP Vaccines Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market

4.2. Ukraine-Russia War Impact On The Market

4.3. COVID-19 Impact On The Market

5. Global DTP Vaccines Market Size and Growth

5.1. Global DTP Vaccines Market Drivers and Restraints

5.1.1. Drivers Of The Market

5.1.2. Restraints Of The Market

5.2. Global DTP Vaccines Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

5.3. Global DTP Vaccines Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. DTP Vaccines Market Segmentation

6.1. Global DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

DTaP

Tdap

6.2. Global DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Diphtheria

Pertussis

Tetanus.

6.3. Global DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Hospitals

Clinics

Vaccination Centers

7. DTP Vaccines Market Regional And Country Analysis

7.1. Global DTP Vaccines Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

7.2. Global DTP Vaccines Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific DTP Vaccines Market

8.1. Asia-Pacific DTP Vaccines Market Overview

Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8.3. Asia-Pacific DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8.4. Asia-Pacific DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China DTP Vaccines Market

9.1. China DTP Vaccines Market Overview

9.2. China DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

9.3. China DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

9.4. China DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India DTP Vaccines Market

10.1. India DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10.2. India DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10.3. India DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan DTP Vaccines Market

11.1. Japan DTP Vaccines Market Overview

11.2. Japan DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11.3. Japan DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11.4. Japan DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia DTP Vaccines Market

12.1. Australia DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12.2. Australia DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12.3. Australia DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia DTP Vaccines Market

13.1. Indonesia DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13.2. Indonesia DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13.3. Indonesia DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea DTP Vaccines Market

14.1. South Korea DTP Vaccines Market Overview

14.2. South Korea DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14.3. South Korea DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14.4. South Korea DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe DTP Vaccines Market

15.1. Western Europe DTP Vaccines Market Overview

15.2. Western Europe DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15.3. Western Europe DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15.4. Western Europe DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK DTP Vaccines Market

16.1. UK DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16.2. UK DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16.3. UK DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany DTP Vaccines Market

17.1. Germany DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17.2. Germany DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17.3. Germany DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France DTP Vaccines Market

18.1. France DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18.2. France DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18.3. France DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy DTP Vaccines Market

19.1. Italy DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19.2. Italy DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19.3. Italy DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain DTP Vaccines Market

20.1. Spain DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20.2. Spain DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20.3. Spain DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe DTP Vaccines Market

21.1. Eastern Europe DTP Vaccines Market Overview

21.2. Eastern Europe DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21.3. Eastern Europe DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21.4. Eastern Europe DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia DTP Vaccines Market

22.1. Russia DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22.2. Russia DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22.3. Russia DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America DTP Vaccines Market

23.1. North America DTP Vaccines Market Overview

23.2. North America DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23.3. North America DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23.4. North America DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA DTP Vaccines Market

24.1. USA DTP Vaccines Market Overview

24.2. USA DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24.3. USA DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24.4. USA DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada DTP Vaccines Market

25.1. Canada DTP Vaccines Market Overview

25.2. Canada DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25.3. Canada DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25.4. Canada DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America DTP Vaccines Market

26.1. South America DTP Vaccines Market Overview

26.2. South America DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26.3. South America DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26.4. South America DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil DTP Vaccines Market

27.1. Brazil DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27.2. Brazil DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27.3. Brazil DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East DTP Vaccines Market

28.1. Middle East DTP Vaccines Market Overview

28.2. Middle East DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28.3. Middle East DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28.4. Middle East DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa DTP Vaccines Market

29.1. Africa DTP Vaccines Market Overview

29.2. Africa DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29.3. Africa DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29.4. Africa DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. DTP Vaccines Market Competitive Landscape And Company Profiles

30.1. DTP Vaccines Market Competitive Landscape

30.2. DTP Vaccines Market Company Profiles

30.2.1. GlaxoSmithKline

30.2.1.1. Overview

30.2.1.2. Products and Services

30.2.1.3. Strategy

30.2.1.4. Financial Performance

30.2.2. Sanofi

30.2.2.1. Overview

30.2.2.2. Products and Services

30.2.2.3. Strategy

30.2.2.4. Financial Performance

30.2.3. Merck & Co Inc

30.2.3.1. Overview

30.2.3.2. Products and Services

30.2.3.3. Strategy

30.2.3.4. Financial Performance

30.2.4. Meiji Holdings Co., Ltd

30.2.4.1. Overview

30.2.4.2. Products and Services

30.2.4.3. Strategy

30.2.4.4. Financial Performance

30.2.5. Shenzhen Kangtai Biological Products

30.2.5.1. Overview

30.2.5.2. Products and Services

30.2.5.3. Strategy

30.2.5.4. Financial Performance

31. DTP Vaccines Market Other Major And Innovative Companies

31.1. Serum Institute of India Pvt Ltd

31.2. Sun Pharmaceutical Industries Ltd

31.3. AJ Vaccines

31.4. PT Bio Farma

31.5. Bio Med

31.6. Sinergium Biotech SA

31.7. Teuto Brasileiro

31.8. Amgen

31.9. Roche

31.10. BioFabri

31.11. Sinopharm

31.12. Chongqing Zhifei

31.13. Hualan Biological Engineering Inc

31.14. Ezequiel Dias Foundation (FUNED)

31.15. BioKangtai

32. Global DTP Vaccines Market Competitive Benchmarking

33. Global DTP Vaccines Market Competitive Dashboard

34. Key Mergers And Acquisitions In The DTP Vaccines Market

35. DTP Vaccines Market Future Outlook and Potential Analysis

35.1 DTP Vaccines Market In 2028 - Countries Offering Most New Opportunities

35.2 DTP Vaccines Market In 2028 - Segments Offering Most New Opportunities

35.3 DTP Vaccines Market In 2028 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2018-2023, $ Billion

Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion

Table 3: Global DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 4: Global DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 5: Global DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 6: Global DTP Vaccines Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 7: Global DTP Vaccines Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 8: Asia-Pacific, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 9: Asia-Pacific, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 10: Asia-Pacific, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 11: China, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 12: China, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 13: China, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 14: India, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 15: India, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 16: India, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 17: Japan, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 18: Japan, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 19: Japan, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 20: Australia, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 21: Australia, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 22: Australia, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 23: Indonesia, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 24: Indonesia, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 25: Indonesia, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 26: South Korea, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 27: South Korea, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 28: South Korea, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 29: Western Europe, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 30: Western Europe, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 31: Western Europe, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 32: UK, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 33: UK, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 34: UK, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 35: Germany, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 36: Germany, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 37: Germany, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 38: France, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 39: France, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 40: France, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 41: Italy, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 42: Italy, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 43: Italy, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 44: Spain, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 45: Spain, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 46: Spain, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 47: Eastern Europe, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 48: Eastern Europe, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 49: Eastern Europe, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 50: Russia, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 51: Russia, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 52: Russia, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 53: North America, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 54: North America, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 55: North America, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 56: USA, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 57: USA, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 58: USA, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 59: Canada, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 60: Canada, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 61: Canada, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 62: South America, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 63: South America, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 64: South America, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 65: Brazil, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 66: Brazil, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 67: Brazil, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 68: Middle East, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 69: Middle East, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 70: Middle East, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 71: Africa, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 72: Africa, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 73: Africa, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 74: GlaxoSmithKline Financial Performance

Table 75: Sanofi Financial Performance

Table 76: Merck & Co Inc Financial Performance

Table 77: Meiji Holdings Co., Ltd Financial Performance

Table 78: Shenzhen Kangtai Biological Products Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2018-2023, $ Billion

Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion

Figure 3: Global DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 4: Global DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 5: Global DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 6: Global DTP Vaccines Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 7: Global DTP Vaccines Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 8: Asia-Pacific, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 9: Asia-Pacific, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 10: Asia-Pacific, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 11: China, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 12: China, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 13: China, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 14: India, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 15: India, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 16: India, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 17: Japan, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 18: Japan, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 19: Japan, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 20: Australia, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 21: Australia, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 22: Australia, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 23: Indonesia, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 24: Indonesia, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 25: Indonesia, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 26: South Korea, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 27: South Korea, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 28: South Korea, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 29: Western Europe, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 30: Western Europe, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 31: Western Europe, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 32: UK, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 33: UK, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 34: UK, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 35: Germany, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 36: Germany, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 37: Germany, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 38: France, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 39: France, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 40: France, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 41: Italy, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 42: Italy, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 43: Italy, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 44: Spain, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 45: Spain, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 46: Spain, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 47: Eastern Europe, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 48: Eastern Europe, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 49: Eastern Europe, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 50: Russia, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 51: Russia, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 52: Russia, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 53: North America, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 54: North America, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 55: North America, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 56: USA, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 57: USA, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 58: USA, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 59: Canada, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 60: Canada, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 61: Canada, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 62: South America, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 63: South America, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 64: South America, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 65: Brazil, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 66: Brazil, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 67: Brazil, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 68: Middle East, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 69: Middle East, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 70: Middle East, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 71: Africa, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 72: Africa, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 73: Africa, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 74: GlaxoSmithKline Financial Performance

Figure 75: Sanofi Financial Performance

Figure 76: Merck & Co Inc Financial Performance

Figure 77: Meiji Holdings Co., Ltd Financial Performance

Figure 78: Shenzhen Kangtai Biological Products Financial Performance

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company

Global Gene Therapy Market 2022 – Market Opportunities And Strategies

The Microbiome Market Share, Market Size, And Growth Rate 2022

Latest TNF Alpha Inhibitors Market Growth Study 2022-2026 By The Business Research Company

The Business Research Company offers the nucleic acid based gene therapy market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the radiopharmaceuticals market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the pegfilgrastim biosimilars market market research report 2022 with industry size, share, segments and market growth

Companion Animal Veterinary Vaccines Global Market Report 2024 – By Product (Inactivated, Live Attenuated, Recombinant, Other Products), By Route Of Administration (Oral, Parenteral, Other Routes Of Administration), By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacies And Drug Stores, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Liposomal Drug Delivery Devices Global Market Report 2024 – By Type (Liposomal Doxorubicin, Liposomal Paclitaxel, Liposomal Amphotericin B, Other Types), By Application (Fungal Diseases, Cancer Therapy, Pain Management, Viral Vaccines, Photodynamic Therapy), By End User (Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Cancer biologics Global Market Report 2024 – By Type (Monoclonal Antibodies, Vaccines, Cell And Gene Therapy, Other Types), By Application (Non-small Cell Lung Cancer, Prostate Cancer, Breast Cancer, Acute Myeloid Leukemia, Lymphoma, Multiple Myeloma, Ovarian Cancer, Colorectal Cancer, Gastric Cancers, Other Applications), By Distribution Channel (Hospitals, Clinics, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Drugs for Immunotherapy Global Market Report 2024 – By Type (Monoclonal Antibodies, Interferons, Interleukins, Vaccines, Checkpoint Inhibitors, Other Types), By Therapy Area (Cancer, Autoimmune & Inflammatory Diseases, Infectious Diseases, Other Therapy Areas), By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Therapeutic Proteins Global Market Report 2024 – By Product Type (Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, Follicle Stimulating Hormone), By Function (Enzymatic and Regulatory Activity, Special Targeting Activity, Vaccines, Protein Diagnostics), By Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Veterinary Vaccines Global Market Report 2024 – By Application (Livestock Vaccines, Companion Animal Vaccines), By Vaccine Type (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Other Vaccine Types), By Disease Type (Anaplasmosis, Canine Parvovirus, Foot And Mouth Disease, Newcastle Disease, Distemper Disease, Influenza, Porcine Reproductive And Respiratory Syndrome (PRRS)) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Immuno-Oncology Drugs Global Market Report 2024 – By Type (Immune Checkpoint Inhibitors, Immune System Modulators, Other Monoclonal Antibodies, Cancer Vaccines, Others), By Therapeutic Application (Melanoma, Lung Cancer, Blood Cancer, Renal Cell Carcinoma, Bladder Cancer, Other Therapeutic Application), By End-Users (Hospitals, Clinics, Ambulatory Surgical Centers, Others) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Vaccines Global Market Report 2022 – By Type (Anti-Infective Vaccines, Autoimmunity, Others (Cancer And Others)), By Technology (Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines), By Route of Administration (Intramuscular (IM), Subcutaneous (SC), Oral, Others), By Valance (Monovalent, Multivalent), By Distribution Channel (Institutional Sale, Hospital Pharmacies, Retail Pharmacies) – Market Size, Trends, And Global Forecast 2022-2026

View Report

Frequently Asked Questions

What is the definition of the DTP vaccines market?

How will the DTP vaccines market drivers and restraints affect the DTP vaccines market dynamics? What forces will shape the DTP vaccines industry going forward?

The DTP vaccines market major growth driver - Government Initiatives Propel Development And Adoption Of Dtp Vaccines. For further insights on the DTP vaccines market, request a sample here

What is the forecast market size or the forecast market value of the DTP vaccines market?

The DTP vaccines market size has grown strongly in recent years. It will grow from $6.13 billion in 2023 to $6.56 billion in 2024 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to increase in healthcare access, continuous protection towards infectious diseases and rising awareness of immunization. The DTP vaccines market size is expected to see strong growth in the next few years. It will grow to $8.63 billion in 2028 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to strong late-stage pipeline and new drug approvals, increased healthcare expenditure and immunization policies to eradicate endemic diseases. Major trends in the forecast period include focusing on development of combination vaccines, investing extensively in r&d activities, using artificial intelligence (ai) in vaccine development and focusing on strategic acquisitions. For further insights on the DTP vaccines market, request a sample here

How is the DTP vaccines market segmented?

The DTP vaccines market is segmented
1) By Product type: DTaP, TD, Tdap
2) By Disease: Diphtheria, Pertussis, Tetanus
3) By End-User: Hospitals, Clinics, Vaccination CentersFor further insights on the DTP vaccines market, request a sample here

Which region has the largest share of the DTP vaccines market? What are the other regions covered in the report?

North America was the largest region in the DTP vaccines market in 2023. The regions covered in the DTP vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the DTP vaccines market, request a sample here.

Who are the major players in the DTP vaccines market?

Major companies operating in the DTP vaccines market report are GlaxoSmithKline, Sanofi, Merck & Co Inc, Meiji Holdings Co., Ltd, Shenzhen Kangtai Biological Products, Serum Institute of India Pvt Ltd, Sun Pharmaceutical Industries Ltd, AJ Vaccines, PT Bio Farma, Bio Med, Sinergium Biotech SA, Teuto Brasileiro, Amgen, Roche, BioFabri, Sinopharm, Chongqing Zhifei, Hualan Biological Engineering Inc, Ezequiel Dias Foundation (FUNED), BioKangtai, Uniao Quimica, Valneva SE, The Abu Dhabi Health Services Company (SEHA), ImevaX GmbH, Cristalia, Bharat Biotech, Bio-Manguinhos–Institute of Technology on Immunobiologicals, Connaught Laboratories Inc, Biolab Farmaceutica, Massbiologics, Beijing Tiantan Biological Products Co Ltd, Butantan Institute, C.R.I. Kasauli, Bayer, Pfizer, Abbott Laboratories, Serum Institute of India Pvt Ltd, Novartis, Wyeth-Ayerst, Dano Vaccines, Merck Serono Middle East, Hypermarcas, AstraZeneca, Grifols, Sinovac Biotech Ltd, AbbVie Inc, Apotex, GreenSignal Bio Pharma Private Limited (GSBPL), Teva Pharmaceutical Industries Ltd F. Hoffmann-La Roche AG, Boehringer Ingelheim, CanSino Biologics, Gilead Sciences, Panacea Biotec Ltd, Fiocruz, Johnson & Johnson, Walvax biotechnology, BioNTech, EMS Pharma, Mylan, National Administration of Laboratories and Institutes of Health (ANLIS), Zentiva, Afrigen Biologics & Vaccines For further insights on the DTP vaccines market, request a sample here.

What are the key trends in the DTP vaccines market?

Major trend in the DTP vaccines market - Innovative In Vaccine Paving The Way For Enhanced Protection Of Adolescents, Adults, And Unborn Children. For further insights on the DTP vaccines market, request a sample here.

What are the major opportunities in the DTP vaccines market? What are the strategies for the DTP vaccines market?

For detailed insights on the major opportunities and strategies in the DTP vaccines market, request a sample here.

How does the DTP vaccines market relate to the overall economy and other similar markets?

For detailed insights on DTP vaccines market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the DTP vaccines industry?

For detailed insights on the mergers and acquisitions in the DTP vaccines industry, request a sample here.

What are the key dynamics influencing the DTP vaccines market growth? SWOT analysis of the DTP vaccines market.

For detailed insights on the key dynamics influencing the DTP vaccines market growth and SWOT analysis of the DTP vaccines industry, request a sample here.